Profiel
Theo H.
Walthie is currently a Member-Supervisory Board at LANXESS Deutschland GmbH.
Previously, he served as Chairman at NBE-Therapeutics AG.
He also held the position of Global Business President-Hydrocarbons & Energy at The Dow Chemical Co. from 1970 to 2007.
Additionally, he was a Member-Supervisory Board at Lanxess AG from 2010 to 2022.
Mr. Walthie obtained his undergraduate degree from Delft University of Technology.
Actieve functies van Theo H. Walthie
| Bedrijven | Functie | Begin |
|---|---|---|
LANXESS Deutschland GmbH
LANXESS Deutschland GmbH Chemicals: SpecialtyProcess Industries Produces and sells chemicals | Directeur/Bestuurslid | - |
Eerdere bekende functies van Theo H. Walthie
| Bedrijven | Functie | Einde |
|---|---|---|
| LANXESS AG | Directeur/Bestuurslid | 25-05-2022 |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Voorzitter | 10-08-2020 |
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | 01-01-2007 |
Opleiding van Theo H. Walthie
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
LANXESS AG
LANXESS AG Chemicals: Major DiversifiedProcess Industries Produces and sells specialty additives, intermediaries and engineering materials | Process Industries |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LANXESS Deutschland GmbH
LANXESS Deutschland GmbH Chemicals: SpecialtyProcess Industries Produces and sells chemicals | Process Industries |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
















